BACKGROUND: Inadequate perioperative fluid therapy impairs gastrointestinal function. Studies primarily evaluating the impact of goal-directed fluid therapy on primary postoperative ileus are missing. The objective of this study was to determine whether goal-directed fluid therapy reduces the incidence of primary postoperative ileus after laparoscopic colorectal surgery within an Enhanced Recovery After Surgery program. METHODS: Randomized patient and assessor-blind controlled trial conducted in adult patients undergoing laparoscopic colorectal surgery within an Enhanced Recovery After Surgery program. Patients were assigned randomly to receive intraoperative goal-directed fluid therapy (goal-directed fluid therapy group) or fluid therapy based on traditional principles (control group). Primary postoperative ileus was the primary outcome. RESULTS:One hundred twenty-eight patients were included and analyzed (goal-directed fluid therapy group: n = 64; control group: n = 64). The incidence of primary postoperative ileus was 22% in the goal-directed fluid therapy and 22% in the control group (relative risk, 1; 95% CI, 0.5 to 1.9; P = 1.00). Intraoperatively, patients in the goal-directed fluid therapy group received less intravenous fluids (mainly less crystalloids) but a greater volume of colloids. The increase of stroke volume and cardiac output was more pronounced and sustained in the goal-directed fluid therapy group. Length of hospital stay, 30-day postoperative morbidity, and mortality were not different. CONCLUSIONS:Intraoperative goal-directed fluid therapy compared with fluid therapy based on traditional principles does not reduce primary postoperative ileus in patients undergoing laparoscopic colorectal surgery in the context of an Enhanced Recovery After Surgery program. Its previously demonstrated benefits might have been offset by advancements in perioperative care.
RCT Entities:
BACKGROUND: Inadequate perioperative fluid therapy impairs gastrointestinal function. Studies primarily evaluating the impact of goal-directed fluid therapy on primary postoperative ileus are missing. The objective of this study was to determine whether goal-directed fluid therapy reduces the incidence of primary postoperative ileus after laparoscopic colorectal surgery within an Enhanced Recovery After Surgery program. METHODS: Randomized patient and assessor-blind controlled trial conducted in adult patients undergoing laparoscopic colorectal surgery within an Enhanced Recovery After Surgery program. Patients were assigned randomly to receive intraoperative goal-directed fluid therapy (goal-directed fluid therapy group) or fluid therapy based on traditional principles (control group). Primary postoperative ileus was the primary outcome. RESULTS: One hundred twenty-eight patients were included and analyzed (goal-directed fluid therapy group: n = 64; control group: n = 64). The incidence of primary postoperative ileus was 22% in the goal-directed fluid therapy and 22% in the control group (relative risk, 1; 95% CI, 0.5 to 1.9; P = 1.00). Intraoperatively, patients in the goal-directed fluid therapy group received less intravenous fluids (mainly less crystalloids) but a greater volume of colloids. The increase of stroke volume and cardiac output was more pronounced and sustained in the goal-directed fluid therapy group. Length of hospital stay, 30-day postoperative morbidity, and mortality were not different. CONCLUSIONS: Intraoperative goal-directed fluid therapy compared with fluid therapy based on traditional principles does not reduce primary postoperative ileus in patients undergoing laparoscopic colorectal surgery in the context of an Enhanced Recovery After Surgery program. Its previously demonstrated benefits might have been offset by advancements in perioperative care.
Authors: Nourah Alsharqawi; Mohsen Alhashemi; Pepa Kaneva; Gabriele Baldini; Julio F Fiore; Liane S Feldman; Lawrence Lee Journal: Surg Endosc Date: 2019-07-30 Impact factor: 4.584
Authors: Amir Elhassan; Ahmed Ahmed; Hamdy Awad; Michelle Humeidan; Viet Nguyen; Elyse M Cornett; Richard D Urman; Alan David Kaye Journal: Curr Pain Headache Rep Date: 2018-08-31
Authors: Andrea Carolina Quiroga-Centeno; Kihara Alejandra Jerez-Torra; Pedro Antonio Martin-Mojica; Sergio Andrés Castañeda-Alfonso; María Emma Castillo-Sánchez; Oscar Fernando Calvo-Corredor; Sergio Alejandro Gómez-Ochoa Journal: World J Surg Date: 2020-05 Impact factor: 3.352
Authors: Vittoria Arslan-Carlon; Kay See Tan; Guido Dalbagni; Alessia C Pedoto; Harry W Herr; Bernard H Bochner; Eugene K Cha; Timothy F Donahue; Mary Fischer; S Machele Donat Journal: Anesthesiology Date: 2020-08 Impact factor: 7.892
Authors: Mohsen Alhashemi; Julio F Fiore; Nadia Safa; Mohammed Al Mahroos; Juan Mata; Nicolò Pecorelli; Gabriele Baldini; Nandini Dendukuri; Barry L Stein; A Sender Liberman; Patrick Charlebois; Franco Carli; Liane S Feldman Journal: Surg Endosc Date: 2018-10-17 Impact factor: 4.584
Authors: Alireza Ghoreifi; Michael F Basin; Saum Ghodoussipour; Soroush T Bazargani; Erfan Amini; Mohammad Aslzare; Jie Cai; Gus Miranda; Shihab Sugeir; Sumeet Bhanvadia; Anne K Schuckman; Siamak Daneshmand; Philip Lumb; Hooman Djaladat Journal: Int Urol Nephrol Date: 2021-06-04 Impact factor: 2.370
Authors: Anna Wrzosek; Joanna Jakowicka-Wordliczek; Renata Zajaczkowska; Wojciech T Serednicki; Milosz Jankowski; Malgorzata M Bala; Mateusz J Swierz; Maciej Polak; Jerzy Wordliczek Journal: Cochrane Database Syst Rev Date: 2019-12-12